Protara Therapeutics, Inc. Profile Avatar - Palmy Investing

Protara Therapeutics, Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell thera…

Biotechnology
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of TARA's Analysis
CIK: 1359931 CUSIP: 74365U107 ISIN: US74365U1079 LEI: - UEI: -
Secondary Listings
TARA has no secondary listings inside our databases.